Dr. Steinman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-498-5710
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980
Weizmann InstitutePost-Doctoral Fellowship, 1975 - 1977- Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1974 - 1975
Stanford Health CareInternship, Transitional Year, 1973 - 1974
Harvard Medical SchoolClass of 1973
Certifications & Licensure
CA State Medical License 1974 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Elected Member National Academy of Sciences, 2015
- Fellow American Association Advancement of Science AAAS, 2015
- Charcot Prize for Lifetime Achievement in MS Researcj International Federation of MS Societies, 2011
- Join now to see all
Publications & Presentations
PubMed
- 214 citationsImmunology of Relapse and Remission in Multiple SclerosisLawrence Steinman
Annual Review of Immunology. 2014-03-21 - 39 citationsMultiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus.Thomas Sajda, Julian Hazelton, Milan Patel, Kristina Seiffert-Sinha, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America. 2016-02-16 - 41 citationsNon-coding plasmid DNA induces IFN-γ in vivo and suppresses autoimmune encephalomyelitisGraciela L. Boccaccio, Felix Mor, Lawrence Steinman
International Immunology. 1999-02-01
Journal Articles
- Engineered DNA Plasmid Reduces Immunity to Dystrophin While Improving Muscle Force in a Model of Gene Therapy of Duchenne DystrophyLawrence Steinman, William H Robinson, Proceedings of the National Academy of Sciences
Press Mentions
Experts Urge Genetic Screening for MS Patients to Help Prevent Rare Treatment-Related Fatal InfectionMarch 17th, 2023- Leading MS/PML Experts Recommend Genetic Testing to Prevent Fatal Brain InfectionMarch 16th, 2023
- TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (Ublituximab-Xiiy) in Multiple Sclerosis to Be Presented at the American Academy of Neurology 75th Annual MeetingMarch 3rd, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
